The results you report are impressive
Repeated measures one-way ANOVA with Dunnetts multiple comparison test assessed percent viability of tirzepatide-treated cells relative to vehicle-treated cells for the MTT assay
pyramidale, radiatum, oriens), morphology (axo-axonic, basket, bi-stratified, ivy, Schaffer collateral-associated cells), and pattern of expression of characteristic proteins (parvalbumin PV, neuropeptide Y, somatostatin SST, cannabinoid receptors of type 1 CBR1, nitric oxide synthase NOS) revealed further diversity of plasticity rules in interneurons (Nissen et al., 2010
doi: 10.1016/j.yfrne.2013.07.005
While this risk hasnt been confirmed in humans, the medication is contraindicated for anyone with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
Zepbound is prescribed when a dual-receptor approach may deliver stronger tirzepatide weight loss outcomes